Phase 2 studies on LG human growth hormone successful
Published: 2005-06-09 06:55:00
Updated: 2005-06-09 06:55:00
LG Life Science announced that the phase II studies on the sustained human growth hormone (LB03002) was successfully completed for the dwarf patients, which presented at a meeting of American Society of Endocrinology 2005 on June 7.
The sustained type of human growth hormone (LB03002) was deve...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
